Trial Outcomes & Findings for MTNR1B SNP*Food Timing Interaction on Glucose Control (NCT NCT03036592)
NCT ID: NCT03036592
Last Updated: 2025-04-16
Results Overview
Glucose levels are measured along 120 minutes corresponding to at early and late condition in each visit. The Area Under the Curve was calculated as the sum of the area of several trapezoids. This trapezoids was obtained at times 0-30 min, 30-60 min, 60-90 min, 90-120 min. The values are the difference between the late and the early condition.
COMPLETED
NA
889 participants
Along 120 minutes in visits 1 and 2
2025-04-16
Participant Flow
1457 patients were recruited from January 2017 to March 2020.
845 of 1457 participants were included in this study. Of those not included, 200 declined to participate, 176 did not meet inclusion criteria, 192 lost to follow-up and 44 did not have the complete data. Nevertheless, because the genotype was not known until finishing recruitment, we cannot add the information in each arm of the started, etc.
Participant milestones
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
Early OGTT: Oral glucose tolerance test using identical mixed 75 gr of glucose under early condition (4 hours before habitual bedtime)
Late OGTT: Oral glucose tolerance test using identical mixed 75 gr of glucose under late condition (1 hour before habitual bedtime)
|
Early OGTT, Then Late OGTT in MTNR1B CG
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
Early OGTT: Oral glucose tolerance test using identical mixed 75 gr of glucose under early condition (4 hours before habitual bedtime)
Late OGTT: Oral glucose tolerance test using identical mixed 75 gr of glucose under late condition (1 hour before habitual bedtime)
|
Early OGTT, Then Late OGTT in MTNR1B GG
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
Early OGTT: Oral glucose tolerance test using identical mixed 75 gr of glucose under early condition (4 hours before habitual bedtime)
Late OGTT: Oral glucose tolerance test using identical mixed 75 gr of glucose under late condition (1 hour before habitual bedtime)
|
Late OGTT, Then Early OGTT in MTNR1B CC
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
Late OGTT: Oral glucose tolerance test using identical mixed 75 gr of glucose under late condition (1 hour before habitual bedtime)
Early OGTT: Oral glucose tolerance test using identical mixed 75 gr of glucose under early condition (4 hours before habitual bedtime)
|
Late OGTT, Then Early OGTT in MTNR1B CG
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
Late OGTT: Oral glucose tolerance test using identical mixed 75 gr of glucose under late condition (1 hour before habitual bedtime)
Early OGTT: Oral glucose tolerance test using identical mixed 75 gr of glucose under early condition (4 hours before habitual bedtime)
|
Late OGTT, Then Early OGTT in MTNR1B GG
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
Late OGTT: Oral glucose tolerance test using identical mixed 75 gr of glucose under late condition (1 hour before habitual bedtime)
|
|---|---|---|---|---|---|---|
|
First Visit (1day)
STARTED
|
221
|
193
|
36
|
202
|
149
|
44
|
|
First Visit (1day)
COMPLETED
|
221
|
193
|
36
|
202
|
149
|
44
|
|
First Visit (1day)
NOT COMPLETED
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Washout (1week)
STARTED
|
221
|
193
|
36
|
202
|
149
|
44
|
|
Washout (1week)
COMPLETED
|
221
|
193
|
36
|
202
|
149
|
44
|
|
Washout (1week)
NOT COMPLETED
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Second Visit (1day)
STARTED
|
221
|
193
|
36
|
202
|
149
|
44
|
|
Second Visit (1day)
COMPLETED
|
221
|
193
|
36
|
202
|
149
|
44
|
|
Second Visit (1day)
NOT COMPLETED
|
0
|
0
|
0
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
MTNR1B SNP*Food Timing Interaction on Glucose Control
Baseline characteristics by cohort
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Total
n=845 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|---|
|
Age, Continuous
|
36 years
STANDARD_DEVIATION 13 • n=39 Participants
|
39 years
STANDARD_DEVIATION 14 • n=41 Participants
|
36 years
STANDARD_DEVIATION 15 • n=35 Participants
|
38 years
STANDARD_DEVIATION 14 • n=31 Participants
|
39 years
STANDARD_DEVIATION 15 • n=146 Participants
|
37 years
STANDARD_DEVIATION 16 • n=19 Participants
|
38 years
STANDARD_DEVIATION 14 • n=147 Participants
|
|
Sex: Female, Male
Female
|
152 Participants
n=39 Participants
|
136 Participants
n=41 Participants
|
30 Participants
n=35 Participants
|
143 Participants
n=31 Participants
|
107 Participants
n=146 Participants
|
32 Participants
n=19 Participants
|
600 Participants
n=147 Participants
|
|
Sex: Female, Male
Male
|
69 Participants
n=39 Participants
|
57 Participants
n=41 Participants
|
6 Participants
n=35 Participants
|
59 Participants
n=31 Participants
|
42 Participants
n=146 Participants
|
12 Participants
n=19 Participants
|
245 Participants
n=147 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=39 Participants
|
0 Participants
n=41 Participants
|
0 Participants
n=35 Participants
|
0 Participants
n=31 Participants
|
0 Participants
n=146 Participants
|
0 Participants
n=19 Participants
|
0 Participants
n=147 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=39 Participants
|
0 Participants
n=41 Participants
|
0 Participants
n=35 Participants
|
0 Participants
n=31 Participants
|
0 Participants
n=146 Participants
|
0 Participants
n=19 Participants
|
0 Participants
n=147 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=39 Participants
|
0 Participants
n=41 Participants
|
0 Participants
n=35 Participants
|
0 Participants
n=31 Participants
|
0 Participants
n=146 Participants
|
0 Participants
n=19 Participants
|
0 Participants
n=147 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=39 Participants
|
0 Participants
n=41 Participants
|
0 Participants
n=35 Participants
|
0 Participants
n=31 Participants
|
0 Participants
n=146 Participants
|
0 Participants
n=19 Participants
|
0 Participants
n=147 Participants
|
|
Race (NIH/OMB)
White
|
221 Participants
n=39 Participants
|
193 Participants
n=41 Participants
|
36 Participants
n=35 Participants
|
202 Participants
n=31 Participants
|
149 Participants
n=146 Participants
|
44 Participants
n=19 Participants
|
845 Participants
n=147 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=39 Participants
|
0 Participants
n=41 Participants
|
0 Participants
n=35 Participants
|
0 Participants
n=31 Participants
|
0 Participants
n=146 Participants
|
0 Participants
n=19 Participants
|
0 Participants
n=147 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=39 Participants
|
0 Participants
n=41 Participants
|
0 Participants
n=35 Participants
|
0 Participants
n=31 Participants
|
0 Participants
n=146 Participants
|
0 Participants
n=19 Participants
|
0 Participants
n=147 Participants
|
PRIMARY outcome
Timeframe: Along 120 minutes in visits 1 and 2Glucose levels are measured along 120 minutes corresponding to at early and late condition in each visit. The Area Under the Curve was calculated as the sum of the area of several trapezoids. This trapezoids was obtained at times 0-30 min, 30-60 min, 60-90 min, 90-120 min. The values are the difference between the late and the early condition.
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Area Under the Curve (AUC) Glucose
AUC_Glucose_LE (Late Eating)
|
291.58 mg*h/dL
Standard Deviation 49.73
|
300.51 mg*h/dL
Standard Deviation 54.60
|
300.61 mg*h/dL
Standard Deviation 61.35
|
300.70 mg*h/dL
Standard Deviation 56.88
|
299.09 mg*h/dL
Standard Deviation 57.74
|
320.32 mg*h/dL
Standard Deviation 63.95
|
|
Area Under the Curve (AUC) Glucose
AUC_Glucose_EE (Early Eating)
|
278.84 mg*h/dL
Standard Deviation 49.12
|
268.92 mg*h/dL
Standard Deviation 48.69
|
260.66 mg*h/dL
Standard Deviation 45.30
|
282.21 mg*h/dL
Standard Deviation 54.89
|
274.91 mg*h/dL
Standard Deviation 55.55
|
282.19 mg*h/dL
Standard Deviation 56.56
|
PRIMARY outcome
Timeframe: Along 120 minutes in visits 1 and 2Disposition Index (DI) is the product of insulin sensitivity times by the amount of insulin secreted in response to blood glucose levels. Disposition index is used as a measure of beta cell function and the ability of the body to dispose of a glucose load. This index was determined by this formula: DI= CIR × ISI, where CIR is the measure Corrected Insulin Response, and ISI is Insulin Sensitivity Index. The values are the difference between the late and the early condition. Higher DI indicates an increased beta cell function and increased ability of the body to dispose of a glucose load.
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Disposition Index (DI)
DI_EE
|
3.44 Index
Standard Deviation 3.03
|
4.59 Index
Standard Deviation 6.42
|
5.04 Index
Standard Deviation 6.14
|
3.54 Index
Standard Deviation 3.04
|
3.83 Index
Standard Deviation 3.84
|
3.96 Index
Standard Deviation 3.61
|
|
Disposition Index (DI)
DI_LE
|
3.33 Index
Standard Deviation 3.66
|
2.97 Index
Standard Deviation 2.55
|
2.78 Index
Standard Deviation 1.67
|
3.19 Index
Standard Deviation 3.34
|
3.19 Index
Standard Deviation 2.50
|
3.04 Index
Standard Deviation 4.46
|
SECONDARY outcome
Timeframe: At minute 30 during the visit 1 and 2.The measure of Corrected Insulin Response (CIR) uses the insulin and glucose levels at minute 30, integrating these values in the formula: CIR= l30/(G30 × (G30 - 70)).The values are the difference between the late and the early conditions. CIR is an index that assesses the insulin secretion capacity of B cells. A low CIR implies hyposecretion in response to glucose levels.
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Corrected Insulin Response (CIR)
CIR_EE
|
0.57 Index
Standard Deviation 0.60
|
0.70 Index
Standard Deviation 1.10
|
0.94 Index
Standard Deviation 1.41
|
0.58 Index
Standard Deviation 0.52
|
0.59 Index
Standard Deviation 0.45
|
0.53 Index
Standard Deviation 0.38
|
|
Corrected Insulin Response (CIR)
CIR_LE
|
0.50 Index
Standard Deviation 0.46
|
0.44 Index
Standard Deviation 0.38
|
0.46 Index
Standard Deviation 0.23
|
0.53 Index
Standard Deviation 0.60
|
0.51 Index
Standard Deviation 0.45
|
0.36 Index
Standard Deviation 0.28
|
SECONDARY outcome
Timeframe: Along 120min in visits 1 and 2Insulin Sensitivity Index is a measurement which integrates fasting glucose and insulin concentrations (0 min) and the mean of the glucose and insulin levels from 0 to 120 minutes (0, 30, 60, 90 and 120 min), from an OGTT, to measure insulin sensitivity. This formula allows its use in clinical settings as well as in large epidemiological studies. The values are the difference between the late and the early condition. Elevated ISI values typically indicate a favorable outcome. This index reflects the body's responsiveness to insulin, a hormone crucial for regulating blood sugar levels. Higher sensitivity to insulin suggests that cells efficiently utilize insulin's signals, promoting better blood sugar management. Lower ISI may lead to challenges in maintaining stable blood glucose levels and is often associated with conditions such as type 2 diabetes and metabolic syndrome.
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Insulin Sensitivity Index (ISI)
ISI_EE
|
7.36 Index
Standard Deviation 5.40
|
7.26 Index
Standard Deviation 4.38
|
6.42 Index
Standard Deviation 3.43
|
7.19 Index
Standard Deviation 5.02
|
7.40 Index
Standard Deviation 5.13
|
7.61 Index
Standard Deviation 3.91
|
|
Insulin Sensitivity Index (ISI)
ISI_LE
|
8.11 Index
Standard Deviation 6.98
|
8.11 Index
Standard Deviation 6.34
|
7.32 Index
Standard Deviation 4.20
|
6.99 Index
Standard Deviation 4.91
|
7.59 Index
Standard Deviation 5.22
|
8.00 Index
Standard Deviation 6.66
|
SECONDARY outcome
Timeframe: At minute 0 in visit 1 and 2.Fasting glucose (or basal glucose) is a simple measurement of glucose concentrations at minute 0 to see how glucose levels rise immediately after an OGTT. The values are the difference between the late and the early condition.
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=212 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Fasting Glucose
Fasting glucose_EE
|
85.25 mg/dL
Standard Deviation 7.73
|
84.36 mg/dL
Standard Deviation 7.25
|
84.05 mg/dL
Standard Deviation 5.75
|
84.37 mg/dL
Standard Deviation 6.84
|
84.69 mg/dL
Standard Deviation 7.71
|
83.01 mg/dL
Standard Deviation 4.90
|
|
Fasting Glucose
Fasting glucose_LE
|
84.09 mg/dL
Standard Deviation 7.15
|
84.92 mg/dL
Standard Deviation 7.07
|
85.70 mg/dL
Standard Deviation 6.90
|
84.70 mg/dL
Standard Deviation 7.74
|
85.53 mg/dL
Standard Deviation 6.8
|
83.87 mg/dL
Standard Deviation 7.51
|
SECONDARY outcome
Timeframe: At minute 0 in visit 1 and 2Fasting insulin (or basal insulin) is a simple measurement of insulin concentrations at minute 0 to see how insulin levels rise immediately after an OGTT.The values are the difference between the late and the early condition.
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Fasting Insulin
Fasting insulin_EE
|
6.70 µU/mL
Standard Deviation 4.51
|
6.30 µU/mL
Standard Deviation 4.28
|
6.88 µU/mL
Standard Deviation 3.73
|
6.67 µU/mL
Standard Deviation 4.73
|
6.16 µU/mL
Standard Deviation 3.58
|
5.63 µU/mL
Standard Deviation 3.69
|
|
Fasting Insulin
Fasting insulin_LE
|
6.13 µU/mL
Standard Deviation 4.48
|
5.70 µU/mL
Standard Deviation 3.65
|
5.71 µU/mL
Standard Deviation 2.73
|
6.50 µU/mL
Standard Deviation 4.56
|
6.09 µU/mL
Standard Deviation 3.83
|
5.52 µU/mL
Standard Deviation 3.32
|
SECONDARY outcome
Timeframe: At baseline and 120 minutes in visit 1 and 2Measurement of serum melatonin is made at time 0 and at time 120 in both the early and late conditions of everyone.
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=158 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=136 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=23 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=136 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=104 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=31 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Serum Melatonin
Melatonin_t120_LE
|
79.36 pg/mL
Standard Deviation 52.24
|
83.92 pg/mL
Standard Deviation 60.28
|
93.83 pg/mL
Standard Deviation 63.71
|
81.07 pg/mL
Standard Deviation 55.86
|
74.06 pg/mL
Standard Deviation 55.72
|
83.80 pg/mL
Standard Deviation 44.87
|
|
Serum Melatonin
Melatonin_t0_EE
|
20.86 pg/mL
Standard Deviation 12.32
|
19.50 pg/mL
Standard Deviation 9.82
|
20.25 pg/mL
Standard Deviation 10.70
|
19.20 pg/mL
Standard Deviation 10.39
|
19.01 pg/mL
Standard Deviation 10.87
|
23.13 pg/mL
Standard Deviation 14.92
|
|
Serum Melatonin
Melatonin_t120_EE
|
25.81 pg/mL
Standard Deviation 17.69
|
26.85 pg/mL
Standard Deviation 22.10
|
25.72 pg/mL
Standard Deviation 19.65
|
25.40 pg/mL
Standard Deviation 18.03
|
21.83 pg/mL
Standard Deviation 13.47
|
29.61 pg/mL
Standard Deviation 26.63
|
|
Serum Melatonin
Melatonin_t0_LE
|
52.69 pg/mL
Standard Deviation 40.34
|
53.16 pg/mL
Standard Deviation 43.69
|
54.24 pg/mL
Standard Deviation 35.21
|
49.32 pg/mL
Standard Deviation 34.39
|
47.16 pg/mL
Standard Deviation 41.14
|
55.33 pg/mL
Standard Deviation 32.39
|
SECONDARY outcome
Timeframe: Melatonin measured every half hour for 5 hours at Early condition in all participantsPopulation: We only performed this measure at the early condition in each arm
This measurement shows the decimal time of the onset of melatonin in dim light conditions. In the case of DLMO, we only performed this measure at the early condition in order to get the analysis of melatonin during 5 hours (4 hours before the habitual bedtime and 1 hour later), as it is described in literature (DOI: 10.1002/oby.23749).
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=43 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=40 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=12 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=42 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=29 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=8 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Dim Light Melatonin Onset (DLMO) at Early Condition Only
|
22.42 decimal hours
Standard Deviation 1.33
|
22.03 decimal hours
Standard Deviation 1.06
|
22.41 decimal hours
Standard Deviation 0.92
|
22.50 decimal hours
Standard Deviation 1.38
|
22.08 decimal hours
Standard Deviation 1.13
|
22.39 decimal hours
Standard Deviation 1.40
|
OTHER_PRE_SPECIFIED outcome
Timeframe: For 1 week between visit 1 and 2Measured using a temperature sensor which records the temperature during 7 days. We only determined it during the washout period (neither early nor late conditions).
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Temperature Record (Mean Value 10hours Daytime)
|
32.94 centigrade degrees
Standard Deviation 0.98
|
32.95 centigrade degrees
Standard Deviation 1.09
|
33.24 centigrade degrees
Standard Deviation 0.94
|
33.05 centigrade degrees
Standard Deviation 0.98
|
32.91 centigrade degrees
Standard Deviation 0.93
|
33.02 centigrade degrees
Standard Deviation 0.95
|
OTHER_PRE_SPECIFIED outcome
Timeframe: For 1 week between visit 1 and 2During the seven days of the study, individuals wore a wristwatch in their non-dominant hand, that integrates two sensors: a temperature sensor, and an accelerometer sensor that records physical activity and body position data (G Acceleration Data Logger UA-004-64; Onset Computer, Bourne, MA, USA). Activity was expressed as the change in degrees per minute (Δ°/min). We calculated the average activity value during the 10 consecutive hours of maximum values. We only determined it during the washout period (neither early nor late conditions).
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Activity Record (Mean Value 10hours Daytime)
|
42.69 changes in degrees/min (Δ°/min)
Standard Deviation 8.51
|
51.61 changes in degrees/min (Δ°/min)
Standard Deviation 85.33
|
42.62 changes in degrees/min (Δ°/min)
Standard Deviation 6.46
|
41.73 changes in degrees/min (Δ°/min)
Standard Deviation 9.12
|
43.83 changes in degrees/min (Δ°/min)
Standard Deviation 8.06
|
44.30 changes in degrees/min (Δ°/min)
Standard Deviation 8.31
|
OTHER_PRE_SPECIFIED outcome
Timeframe: For 1 week between the visits 1 and 2Measured using a light sensor during 7 days. We only determined it during the washout period (neither early nor late conditions).
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Light Exposure (Mean Value 10hours Daytime)
|
0.82 Lux log
Standard Deviation 0.24
|
0.83 Lux log
Standard Deviation 0.24
|
0.77 Lux log
Standard Deviation 0.27
|
0.81 Lux log
Standard Deviation 0.25
|
0.81 Lux log
Standard Deviation 0.25
|
0.88 Lux log
Standard Deviation 0.32
|
OTHER_PRE_SPECIFIED outcome
Timeframe: For 1 week between visit 1 and 2Sleep duration will be computed from self-reported. We only determined it during the washout period (neither early nor late conditions).
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Sleep Duration
|
7.43 decimal hours
Standard Deviation 0.75
|
7.52 decimal hours
Standard Deviation 0.79
|
7.58 decimal hours
Standard Deviation 0.70
|
7.56 decimal hours
Standard Deviation 0.82
|
7.46 decimal hours
Standard Deviation 0.88
|
7.51 decimal hours
Standard Deviation 0.69
|
OTHER_PRE_SPECIFIED outcome
Timeframe: For 1 week between visit 1 and 2Total energy intake in kcal/day will be computed with a 7-day dietary log. We only determined it during the washout period (neither early nor late conditions).
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Total Energy Intake
|
1563.64 Kcal/day
Standard Deviation 529.39
|
1548.29 Kcal/day
Standard Deviation 552.64
|
1666.25 Kcal/day
Standard Deviation 633.62
|
1555.96 Kcal/day
Standard Deviation 625.39
|
1619.23 Kcal/day
Standard Deviation 695.37
|
1753.18 Kcal/day
Standard Deviation 719.78
|
OTHER_PRE_SPECIFIED outcome
Timeframe: For 1 week between visit 1 and 2Macronutrient and micronutrient intake will be computed from 7-days of self-reported 24-hr dietary recalls. Percentage Kcal respect to the Total Energy Intake. We only determined it during the washout period (neither early nor late conditions).
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Dietary Composition
Fat
|
34.85 percentage
Standard Deviation 7.01
|
33.95 percentage
Standard Deviation 7.37
|
36.04 percentage
Standard Deviation 8.25
|
33.94 percentage
Standard Deviation 7.83
|
34.90 percentage
Standard Deviation 8.04
|
35.85 percentage
Standard Deviation 8.49
|
|
Dietary Composition
Proteins
|
17.52 percentage
Standard Deviation 3.41
|
18.26 percentage
Standard Deviation 3.94
|
18.02 percentage
Standard Deviation 3.92
|
18.18 percentage
Standard Deviation 3.95
|
18.24 percentage
Standard Deviation 3.48
|
17.57 percentage
Standard Deviation 3.65
|
|
Dietary Composition
Carbohydrates
|
47.17 percentage
Standard Deviation 7.66
|
47.75 percentage
Standard Deviation 7.42
|
46.85 percentage
Standard Deviation 7.38
|
47.82 percentage
Standard Deviation 8.33
|
46.64 percentage
Standard Deviation 8.49
|
46.68 percentage
Standard Deviation 7.58
|
OTHER_PRE_SPECIFIED outcome
Timeframe: For 1 week between visit 1 and 2Food timing will be self-reported and averaged across 7-days of 24-hour dietary recalls. We only determined it during the washout period (neither early nor late conditions).
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Dietary Intake Timing
Start breakfast
|
8.72 decimal hours
Standard Deviation 0.98
|
8.68 decimal hours
Standard Deviation 0.87
|
8.80 decimal hours
Standard Deviation 0.92
|
8.74 decimal hours
Standard Deviation 0.92
|
8.68 decimal hours
Standard Deviation 0.83
|
8.66 decimal hours
Standard Deviation 0.96
|
|
Dietary Intake Timing
Start lunch
|
14.66 decimal hours
Standard Deviation 0.49
|
14.72 decimal hours
Standard Deviation 0.53
|
14.60 decimal hours
Standard Deviation 0.42
|
14.70 decimal hours
Standard Deviation 0.52
|
14.71 decimal hours
Standard Deviation 0.48
|
14.50 decimal hours
Standard Deviation 0.38
|
|
Dietary Intake Timing
Start dinner
|
21.66 decimal hours
Standard Deviation 0.53
|
21.61 decimal hours
Standard Deviation 0.65
|
21.64 decimal hours
Standard Deviation 0.49
|
21.61 decimal hours
Standard Deviation 0.56
|
21.67 decimal hours
Standard Deviation 0.54
|
21.54 decimal hours
Standard Deviation 0.56
|
OTHER_PRE_SPECIFIED outcome
Timeframe: During the week of washoutAssessed using the International Physical Activity Questionnaire (IPAQ). This international questionnaire measures physical activity through the amount of energy expended carrying out physical activity i.e., Metabolic Units (MET) minutes a week. The higher the MET, the more amount of physical activity the individual performs. This allows us to classify low, moderate, or vigorous activity. 7 or more days of any combination of walking, moderate-intensity or vigorous intensity activities achieving a minimum of at least 3000 MET minutes a week. We only determined it during the washout period (neither early nor late conditions). Formula for computation of Met-minutes: * Walking MET-minutes/week = 3.3 \* walking minutes \* walking "days" * Moderate MET-minutes/week = 4.0 \* moderate-intensity activity minutes \* moderate days * Vigorous MET-minutes/week = 8.0 \* vigorous-intensity activity minutes \* vigorous-intensity days
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Physical Activity
|
4066.98 Metabolic Units (MET)-minutes/week
Standard Deviation 5898.97
|
4548.62 Metabolic Units (MET)-minutes/week
Standard Deviation 5060.76
|
4560.41 Metabolic Units (MET)-minutes/week
Standard Deviation 5779.47
|
4646.63 Metabolic Units (MET)-minutes/week
Standard Deviation 4877.34
|
4429.64 Metabolic Units (MET)-minutes/week
Standard Deviation 5284.58
|
4608.31 Metabolic Units (MET)-minutes/week
Standard Deviation 4765.35
|
OTHER_PRE_SPECIFIED outcome
Timeframe: During the week of washoutAssessed using the Morningness-Eveningness Questionnaire (MEQ). Its main purpose is to measure whether a person's circadian rhythm produces peak alertness in the morning, in the evening, or in between. It is a score that indicates the degree to which the individual favors the morning over the night. We only determined it during the washout period (neither early nor late conditions). Values: Min: 17 Max: 86 Explanation: 17-30: extreme eveningness 31-41: eveningness 42-58: neither 59-69: morningness 70-86: extreme morningness
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Chronotype
|
51.15 score
Standard Deviation 9.42
|
51.75 score
Standard Deviation 8.90
|
49.83 score
Standard Deviation 10.70
|
51.35 score
Standard Deviation 10.15
|
51.65 score
Standard Deviation 10.32
|
51.11 score
Standard Deviation 8.97
|
OTHER_PRE_SPECIFIED outcome
Timeframe: During the week of washoutAssessed using the Emotional Eating Questionnaire (EEQ). This questionnaire classifies individuals based on the relationship between food intake and emotions. Score between 0 and 30. We only determined it during the washout period (neither early nor late conditions). Explanation: 0-5: nothing emotional 5-10: less emotional 10-20: emotional 20-30: Very emotional
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Emotional Eating
|
11.10 score
Standard Deviation 6.26
|
10.64 score
Standard Deviation 5.74
|
11.16 score
Standard Deviation 6.32
|
10.98 score
Standard Deviation 6.16
|
10.81 score
Standard Deviation 6.28
|
10.54 score
Standard Deviation 5.79
|
OTHER_PRE_SPECIFIED outcome
Timeframe: During the week of washoutAssessed using the Pittsburgh Sleep Quality Index (PSQI). This questionnaire is used to quantitatively assess the quality of sleep. 7 scores are obtained that inform us about various aspects of sleep quality. We only determined it during the washout period (neither early nor late conditions). Score between 0 and 21. Total score of the questionnaire is divided into 7 items. Those items have a score from 0 (no problem) to 3 (severe problem). 0-5: sleep quality optimum 6-21: sleep disorders
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Sleep Quality
|
6.05 score
Standard Deviation 3.05
|
6.15 score
Standard Deviation 3.15
|
6.75 score
Standard Deviation 3.25
|
7.00 score
Standard Deviation 3.74
|
6.84 score
Standard Deviation 3.36
|
6.49 score
Standard Deviation 3.29
|
OTHER_PRE_SPECIFIED outcome
Timeframe: During the week of washoutAssessed using the Insomnia Severity Index (ISI). This questionnaire has 5 items and is used to assess the possible existence of sleep problems. According to the score obtained, a classification is made from no insomnia to severe clinical insomnia. We only determined it during the washout period (neither early nor late conditions). Score ranges between 0 and 28 Explanation: 0-7: no insomnia 8-14: subclinical insomnia 15-21: moderate insomnia 22-28: severe insomnia The higher the score, the more harmful
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Insomnia
|
6.44 score
Standard Deviation 4.83
|
6.63 score
Standard Deviation 4.99
|
7.86 score
Standard Deviation 5.48
|
7.04 score
Standard Deviation 5.39
|
6.86 score
Standard Deviation 5.48
|
7.29 score
Standard Deviation 5.97
|
OTHER_PRE_SPECIFIED outcome
Timeframe: During the week of washoutAssessed using the Patient Health Questionnaire (PHQ-9). This instrument aims to help the diagnosis of depression through the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), and to determine the severity of the disorder. It is made up of 9 items that refer to the last two weeks. The score ranges between 0 and 27. We only determined it during the washout period (neither early nor late conditions). 0-4: no depression 5-9: mild depression 10-14: moderate depression 15-19: moderate-severe depression 20-27: severe depression Explanation: 0-4: no depression 5-9: mild depression 10-14: moderate depression 15-19: moderate-severe depression 20-27: severe depression The higher the score, the more harmful
Outcome measures
| Measure |
Early OGTT, Then Late OGTT in MTNR1B CC
n=221 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B CG
n=193 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Early OGTT, Then Late OGTT in MTNR1B GG
n=36 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CC
n=202 Participants
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B CG
n=149 Participants
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
Late OGTT, Then Early OGTT in MTNR1B GG
n=44 Participants
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
|
|---|---|---|---|---|---|---|
|
Depression
|
4.50 score
Standard Deviation 3.89
|
4.61 score
Standard Deviation 4.17
|
4.77 score
Standard Deviation 4.83
|
4.98 score
Standard Deviation 4.52
|
4.57 score
Standard Deviation 3.63
|
5.31 score
Standard Deviation 4.41
|
Adverse Events
Early OGTT (First) in MTNR1B CC
Early OGTT (First) in MTNR1B CG
Early OGTT (First) in MTNR1B GG
Late OGTT (First) in MTNR1B CC
Late OGTT (First) in MTNR1B CG
Late OGTT (First) in MTNR1B GG
Late OGTT (Second) in MTNR1B CC
Late OGTT (Second) in MTNR1B CG
Late OGTT (Second) in MTNR1B GG
Early OGTT (Second) in MTNR1B CC
Early OGTT (Second) in MTNR1B CG
Early OGTT (Second) in MTNR1B GG
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place